论文部分内容阅读
肿瘤患者常合并不同程度的贫血。贫血不仅降低患者的生活质量,还可降低机体对化疗药物的敏感性,影响化疗的顺利进行。红细胞生成素 (EPO)是一种红细胞生成因子,能够促进红细胞生成,其人工合成物-重组人红细胞生成素 (rHuEPO)在慢性肾源性贫血的治疗中普遍应用。我们于 2002
Cancer patients often have different degrees of anemia. Anemia not only reduces the quality of life of patients, but also reduce the body’s sensitivity to chemotherapy drugs, affecting the smooth progress of chemotherapy. Erythropoietin (EPO) is an erythropoietic factor that promotes erythropoiesis and its synthetic product, recombinant human erythropoietin (rHuEPO), is commonly used in the treatment of chronic kidney anemia. We are in 2002